These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 39412819)

  • 1. A First-Passage Model of Intravitreal Drug Delivery and Residence Time-Influence of Ocular Geometry, Individual Variability, and Injection Location.
    Lamirande P; Gaffney EA; Gertz M; Maini PK; Crawshaw JR; Caruso A
    Invest Ophthalmol Vis Sci; 2024 Oct; 65(12):21. PubMed ID: 39412819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular and systemic pharmacokinetics of BI-X, a nanobody targeting VEGF and Ang-2, after intravitreal dosing in cynomolgus monkeys - Evidence for half-life extension by albumin.
    Fuchs H; Chen LZ; Low S; Yu H
    Exp Eye Res; 2021 Apr; 205():108486. PubMed ID: 33571529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular Pharmacokinetics of Therapeutic Antibodies Given by Intravitreal Injection: Estimation of Retinal Permeabilities Using a 3-Compartment Semi-Mechanistic Model.
    Hutton-Smith LA; Gaffney EA; Byrne HM; Maini PK; Gadkar K; Mazer NA
    Mol Pharm; 2017 Aug; 14(8):2690-2696. PubMed ID: 28631484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular Pharmacokinetics of Brimonidine Drug Delivery System in Monkeys and Translational Modeling for Selection of Dose and Frequency in Clinical Trials.
    Tamhane M; Luu KT; Attar M
    J Pharmacol Exp Ther; 2021 Sep; 378(3):207-214. PubMed ID: 34210753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravitreal macromolecules: Scaling between rats and rabbits.
    Sadeghi A; Puranen J; Ruponen M; Valtari A; Subrizi A; Ranta VP; Toropainen E; Urtti A
    Eur J Pharm Sci; 2021 Apr; 159():105720. PubMed ID: 33465477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular Pharmacokinetics of Intravitreally Injected Protein Therapeutics: Comparison among Standard-of-Care Formats.
    Jakubiak P; Alvarez-Sánchez R; Fueth M; Broders O; Kettenberger H; Stubenrauch K; Caruso A
    Mol Pharm; 2021 Jun; 18(6):2208-2217. PubMed ID: 34014104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Half-Life of Intravitreal Biologics in Humans and Other Species: Meta-Analysis and Model-Based Prediction.
    Caruso A; Füth M; Alvarez-Sánchez R; Belli S; Diack C; Maass KF; Schwab D; Kettenberger H; Mazer NA
    Mol Pharm; 2020 Feb; 17(2):695-709. PubMed ID: 31876425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative intravitreal pharmacokinetics in mouse as a step towards inter-species translation.
    Puranen J; Ranta VP; Ruponen M; Urtti A; Sadeghi A
    Exp Eye Res; 2023 Oct; 235():109638. PubMed ID: 37657528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Monoclonal Antibody and Antibody Fragments in The Mouse Eye Following Intravitreal Administration.
    Bussing D; Li Y; Guo L; Verma A; Sullivan JM; Shah DK
    J Pharm Sci; 2023 Aug; 112(8):2276-2284. PubMed ID: 37062415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular tissue distribution and pharmacokinetic study of a small 13kDa domain antibody after intravitreal, subconjuctival and eye drop administration in rabbits.
    Gough G; Szapacs M; Shah T; Clements P; Struble C; Wilson R
    Exp Eye Res; 2018 Feb; 167():14-17. PubMed ID: 29074387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection site and pharmacokinetics after intravitreal injection of immunoglobulin G.
    Miura Y; Uematsu M; Teshima M; Suzuma K; Kumagami T; Sasaki H; Kitaoka T
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):35-41. PubMed ID: 21182428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of short-chain aliphatic alcohols in rabbit vitreous by ocular microdialysis.
    Atluri H; Mitra AK
    Exp Eye Res; 2003 Mar; 76(3):315-20. PubMed ID: 12573660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative pharmacokinetic analyses of anterior and posterior elimination routes of intravitreal anti-VEGF macromolecules using published human and rabbit data.
    Lamminsalo M; Urtti A; Ranta VP
    Exp Eye Res; 2022 Sep; 222():109162. PubMed ID: 35760120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging, quantitation and kinetic modelling of intravitreal nanomaterials.
    Sadeghi A; Ruponen M; Puranen J; Cao S; Ridolfo R; Tavakoli S; Toropainen E; Lajunen T; Ranta VP; van Hest J; Urtti A
    Int J Pharm; 2022 Jun; 621():121800. PubMed ID: 35533923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of P-glycoprotein on the ocular disposition of a model substrate, quinidine.
    Duvvuri S; Gandhi MD; Mitra AK
    Curr Eye Res; 2003 Dec; 27(6):345-53. PubMed ID: 14704918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular silicon distribution and clearance following intravitreal injection of porous silicon microparticles.
    Nieto A; Hou H; Sailor MJ; Freeman WR; Cheng L
    Exp Eye Res; 2013 Nov; 116():161-8. PubMed ID: 24036388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended Pharmacokinetic Model of the Intravitreal Injections of Macromolecules in Rabbits. Part 2: Parameter Estimation Based on Concentration Dynamics in the Vitreous, Retina, and Aqueous Humor.
    Lamminsalo M; Karvinen T; Subrizi A; Urtti A; Ranta VP
    Pharm Res; 2020 Oct; 37(11):226. PubMed ID: 33094404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the Fc Region in the Vitreous Half-Life of Anti-VEGF Drugs.
    Joo K; Park SJ; Choi Y; Lee JE; Na YM; Hong HK; Park KH; Kim HM; Chung JY; Woo SJ
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4261-4267. PubMed ID: 28850637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.
    Cundy KC; Lynch G; Shaw JP; Hitchcock MJ; Lee WA
    Curr Eye Res; 1996 May; 15(5):569-76. PubMed ID: 8670758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.